Published Date: 31-Dec-2019
Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
According to a new report Global L-Carnitine Market, published by KBV Research, The Global L-Carnitine Market size is expected to reach $219.2 Million by 2025, rising at a market growth of 4.56% CAGR during the forecast period.
Due to the growing consumer awareness of the benefits of L-carnitine supplementation, the industry is anticipated to experience substantial growth during the forecast period. The food and pharmaceutical grade segment recorded the highest market share in 2018 and in the years to come, is projected to witness significant growth. In addition, it is estimated that the increased use of L-carnitine and its animal feed derivatives will fuel market growth over the forecast period.
The Healthcare Product market dominated the Global L-Carnitine Market by Application in 2018, growing at a CAGR of 3.9 % during the forecast period. The Functional Drink market is experiencing a CAGR of 4% during (2019 - 2025).
The Chemical Synthesis market dominated the Global L-Carnitine Market by Process in 2018, growing at a CAGR of 4.2 % during the forecast period. The Bioprocess market is anticipated to witness a CAGR of 5.1% during (2019 - 2025).
The North America market dominated the Global L-Carnitine Market by Region in 2018. The Europe market is expected to witness a CAGR of 3.9% during (2019 - 2025). Additionally, The Asia Pacific market is poised to witness highest CAGR of 5.4% during (2019 - 2025).
Structural Insights: https://www.kbvresearch.com/l-carnitine-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Merck Group, Lonza Group AG, Northeast Pharmaceutical Group Co. Ltd., Cayman Chemical Company, Inc., Tokyo Chemical Industry Co. Ltd., Ceva Sante Animale S.A., Kaiyuan Hengtai Chemical Co., Ltd., ChengDa Pharmaceuticals Co., Ltd., HuangGang HuaYang Pharmaceutical Co., Ltd., and HuBei YuanCheng SaiChuang Technology Co. Ltd.
Unique Offerings from KBV Research